## ACMR: ACM Research, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.8% in mid entry zone (3.0-6.0%), top quartile (82nd pct) cross-sectional ranking. Caution: MRS_5 (-0.8%) diverging from MRS_10, watch for reversal. Outperforming sector by 5.2%. Caution: momentum weakening (-2.4% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($33.51)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.88M) |
| Sells | 7 ($6.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Blackrock Inc.: 12.7% (+84.8%)
- Vanguard Group Inc: 8.1% (+12.8%)
- LSV Asset Management: 4.2% (+462.9%)
- Triata Capital Ltd: 3.4% (+26.0%)
- State Street Corpora: 3.3% (+58.6%)

### Key Risks

1. Insider selling cluster: $6.1M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Balance sheet: strong liquidity (3.5x). Insider selling cluster ($6.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.4B |
| Beta | 1.45 |
| 52W Range | $14.65 - $45.12 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 18.1 |
| Current P/E | 20.6 |
| YoY Growth | 13.5% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 7.2% to 4.8% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 82nd percentile. MRS_5 (-0.8%) diverging from MRS_10 - short-term weakness emerging. Outperforming sector by 5.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.79), confirming momentum. RSI neutral at 58. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.83% (CS: 83) | Strong |
| RSI_14 | 58.0 | Neutral |
| MACD Histogram | 0.79 | Bullish |
| vs SMA20 | 1.103x | Above |
| vs SMA50 | 1.035x | Above |
| vs SMA200 | 1.298x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $37.73
- **Stop Loss:** $33.51 (11.2% risk)
- **Target:** $44.06 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 236
- **Position Value:** $8,904.28
- **Portfolio %:** 8.90%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-25 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.53 | $0.36 | -32.4% |
| 2025Q2 | $0.50 | $0.54 | +7.5% |
| 2025Q1 | $0.35 | $0.46 | +32.4% |
| 2024Q4 | $0.39 | $0.56 | +44.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*